SCHRöDINGER
Schrödinger’s industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions and government laboratories worldwide. Schrödinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas. Schrödinger is deeply committed to investing in the science and talent that drive its computational platform. Schrödinger was founded in 1990, has over 700 employees and is engaged with customers and collaborators in more than 70 countries. To learn more visit www.schrodinger.com.
SCHRöDINGER
Industry:
Biotechnology Enterprise Software Pharmaceutical Software
Founded:
1990-08-16
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.schrodinger.com
Total Employee:
501+
Status:
Active
Contact:
1 503 299 1150
Total Funding:
567.22 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Font Awesome Domain Not Resolving Apache
Similar Organizations
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Dls Solutions Inc
DLS Solutions develops custom software for analytical and biotechnology instrumentation.
MolecularWare
MolecularWare develops data management software for high throughput biology.
Reify
Reify develops and markets machine vision and video analysis software-based phenotypic screens for the biotechnology industries.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-01-18 | Xtal BioStructures | Xtal BioStructures acquired by Schrödinger | 6 M USD |
Investors List
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Schrödinger
Pavilion Capital
Pavilion Capital investment in Series E - Schrödinger
Michael Antonov
Michael Antonov investment in Series E - Schrödinger
Invus
Invus investment in Series E - Schrödinger
Laurion Capital Management
Laurion Capital Management investment in Series E - Schrödinger
Sixty Degree Capital
Sixty Degree Capital investment in Series E - Schrödinger
Formic Ventures
Formic Ventures investment in Venture Round - Schrödinger
GV
GV investment in Series E - Schrödinger
WuXi AppTec
WuXi AppTec investment in Series E - Schrödinger
Deerfield
Deerfield investment in Series E - Schrödinger
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-10-20 | ShouTi | Schrödinger investment in Series B - ShouTi | 100 M USD |
| 2021-06-01 | Ajax Therapeutics | Schrödinger investment in Venture Round - Ajax Therapeutics | 40 M USD |
| 2019-12-03 | Bright Angel Therapeutics | Schrödinger investment in Seed Round - Bright Angel Therapeutics | N/A |
| 2018-09-25 | Morphic Therapeutic | Schrödinger investment in Series B - Morphic Therapeutic | 80 M USD |
| 2018-06-05 | Nimbus Therapeutics | Schrödinger investment in Series C - Nimbus Therapeutics | 65 M USD |
| 2016-06-30 | Morphic Therapeutic | Schrödinger investment in Series A - Morphic Therapeutic | 51.5 M USD |
| 2016-01-01 | Morphic Therapeutic | Schrödinger investment in Seed Round - Morphic Therapeutic | 3 M USD |
| 2010-04-29 | Nimbus Therapeutics | Schrödinger investment in Seed Round - Nimbus Therapeutics | 3.5 M USD |
Newest Events participated
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-18 | Schrödinger Appoints Geoffrey Porges as Chief Financial Officer |
Official Site Inspections
http://www.schrodinger.com Semrush global rank: 338.39 K Semrush visits lastest month: 178.24 K
- Host name: 192.0.66.218
- IP address: 192.0.66.218
- Location: San Francisco United States
- Latitude: 37.7506
- Longitude: -122.4121
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94110
More informations about "Schrödinger"
About us - Schrödinger
We are driven to be the world leader in transforming drug discovery and materials design by relentlessly pursuing scientific and technology breakthroughs.; We are committed to achieving …See details»
Our Team - Schrödinger
Proprietary Pipeline Highlights. SGR-1505 (MALT1) SGR-1505 is a mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitor. SGR-2921 (CDC7) SGR-2921 is a …See details»
Schrödinger - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 1 503 299 1150 Schrödinger develops a computational platform that facilitates the research …See details»
Schrödinger - The Org
Schrödinger, LLC is an American software company that develops chemical simulation software for use in pharmaceutical, biotechnology, and materials science research.See details»
Schrödinger, Inc. - Investor Relations
Mar 18, 2025 [email protected]. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field and select at least one alert option. After …See details»
Schrödinger GmbH (München) | CHEManager
May 28, 2020 Schrödinger is continually developing enterprise-level software that can be deployed throughout an entire research organization, and the company is committed to providing integrated software solutions and services …See details»
Schrödinger - Funding, Financials, Valuation
Which industries has this organization had the most exits in? Show . Structure Therapeutics Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR. Morphic …See details»
Working At Schrödinger Inc: Company Overview and …
Mar 14, 2024 Organization Type. Private. CEO. Ramy Farid. Social Media. Schrodinger is a technology company focusing on molecular simulations, enterprise software solutions, and services for pharmaceutical, biotechnology, …See details»
Schrödinger, Inc. (SDGR) Company Profile & Facts
See the company profile for Schrödinger, Inc. (SDGR) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ...See details»
Schrodinger Inc Company Profile - GlobalData
Schrodinger Inc (Schrodinger) is a technology company that provides software solutions for drug discovery. The company offers a computational platform designed with predictive modeling, …See details»
About us - Schrödinger - wp-stg.schrodinger.com
We are driven to be the world leader in transforming drug discovery and materials design by relentlessly pursuing scientific and technology breakthroughs.; We are committed to achieving …See details»
Governance - Documents & Charters - Schrödinger, Inc.
Ombuds Office for Schrödinger Europe. As a global company with operations in Europe, we also offer reporting through an Ombuds Office (or an Ombudslawyer) for Schrödinger GmbH and …See details»
Defining Moments in Schrödinger’s History
About our company. At Schrödinger, you’ll be part of a global team of more than 800 individuals dedicated to improving the health and quality of human life, armed with the knowledge that …See details»
Schrödinger - Most Loved Workplace®
About The Company. Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables …See details»
Schrödinger, Inc. - Schrödinger Announces Multi-Target …
Nov 12, 2024 Schrödinger to receive $150 million upfront and eligible to receive up to approximately $2.3 billion in milestone payments plus royalties Expanded multi-year software …See details»
Welcome to Schrödinger’s Stock Market - WSJ
United’s decision to give dueling earnings guidance is mind-bending for investorsSee details»
Corporate Sustainability - Schrödinger
As part of a suite of benefits, employees who work at least 25 hours per week are provided a paid day off each year to volunteer with an organization or program of their choice. Additionally, …See details»
Schrödinger Poised For Growth As FDA Shifts Away From Animal …
6 days ago Schrödinger’s stock surged after the FDA's initiative to phase out animal testing, benefiting its computational drug discovery platform. Find out why we've rated SDGR as a Buy.See details»
Schrödinger Provides Update on Progress Across the Business and ...
Jan 13, 2025 NEW YORK--(BUSINESS WIRE)-- Schrödinger, Inc. (Nasdaq: SDGR) today provided an update on its progress across the business in 2024 and announced its strategic …See details»
Where Schrödinger’s cat came from – and why it’s getting fatter
Apr 10, 2025 Schrödinger called his metaphorical cat “quite ridiculous” but the quantum weirdness it represents has become a useful benchmark for the quantum computing industry, …See details»